1. Home
  2. SXTP vs MSPR Comparison

SXTP vs MSPR Comparison

Compare SXTP & MSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SXTP
  • MSPR
  • Stock Information
  • Founded
  • SXTP 2010
  • MSPR 2014
  • Country
  • SXTP United States
  • MSPR United States
  • Employees
  • SXTP N/A
  • MSPR N/A
  • Industry
  • SXTP Biotechnology: Pharmaceutical Preparations
  • MSPR
  • Sector
  • SXTP Health Care
  • MSPR
  • Exchange
  • SXTP Nasdaq
  • MSPR NYSE
  • Market Cap
  • SXTP 2.7M
  • MSPR N/A
  • IPO Year
  • SXTP 2023
  • MSPR N/A
  • Fundamental
  • Price
  • SXTP $2.26
  • MSPR $1.90
  • Analyst Decision
  • SXTP Hold
  • MSPR
  • Analyst Count
  • SXTP 1
  • MSPR 0
  • Target Price
  • SXTP N/A
  • MSPR N/A
  • AVG Volume (30 Days)
  • SXTP 457.4K
  • MSPR 4.6M
  • Earning Date
  • SXTP 05-19-2025
  • MSPR 05-19-2025
  • Dividend Yield
  • SXTP N/A
  • MSPR N/A
  • EPS Growth
  • SXTP N/A
  • MSPR N/A
  • EPS
  • SXTP N/A
  • MSPR N/A
  • Revenue
  • SXTP $681,345.00
  • MSPR $18,249,000.00
  • Revenue This Year
  • SXTP $95.50
  • MSPR N/A
  • Revenue Next Year
  • SXTP $80.78
  • MSPR N/A
  • P/E Ratio
  • SXTP N/A
  • MSPR N/A
  • Revenue Growth
  • SXTP 168.70
  • MSPR 574.64
  • 52 Week Low
  • SXTP $1.41
  • MSPR $1.10
  • 52 Week High
  • SXTP $36.00
  • MSPR $22.25
  • Technical
  • Relative Strength Index (RSI)
  • SXTP 43.50
  • MSPR N/A
  • Support Level
  • SXTP $2.21
  • MSPR N/A
  • Resistance Level
  • SXTP $2.45
  • MSPR N/A
  • Average True Range (ATR)
  • SXTP 0.44
  • MSPR 0.00
  • MACD
  • SXTP -0.09
  • MSPR 0.00
  • Stochastic Oscillator
  • SXTP 6.86
  • MSPR 0.00

About SXTP 60 Degrees Pharmaceuticals Inc.

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.

Share on Social Networks: